CO News and Press, Global Cord Blood Corporation From 07/01/21

Global Cord Blood had a decent quarter, with subscriber growth improving both YoY and QoQ. This company is very cheap with 146% net cash to market cap. 24% EPS CAGR over the last 5-year period. Changes in birthing policy in China - will bode well for the company. A market ...

Image source: The Motley Fool. Global Cord Blood Corporation (NYSE: CO) Q4 2021 Earnings Call Jun 29, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Global Cord Blood Corporation (CO) Q4 2021 Earnings Call Transcri...

Global Cord Blood Corporation (CO) Q4 2021 Earnings Conference Call June 29, 2021 8:00 am ET Corporate Participants Cathy Bai - VP of Corporate Finance Albert Chen - Chief Financial Officer Conference Call Participants Sandy Mehta - Evaluate Research Cyrille Pichot - Altimeo Presentation Oper...

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results Earnings Call Scheduled for 8:00 a.m. ET on June 29, 2021 PR Newswire HONG KONG , June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "C...

Shares of Global Cord Blood Corporation (NYSE:CO) traded at a new 52-week high today of $5.17. So far today approximately 100,000 shares have been exchanged, as compared to an average 30-day volume of 221,000 shares. Based on a current price of $5.13, Global Cord Blood Corporation is cur...

Shares of Global Cord Blood Corporation (NYSE:CO) traded today at $4.99, eclipsing its 52-week high. This new high was reached on above average trading volume as 290,000 shares traded hands, while the average 30-day volume is approximately 208,000 shares. Global Cord Blood Corp provides ...

Shares of Global Cord Blood Corporation (NYSE: CO) , a provider of umbilical cord blood stem cells storage, are rising sharply on Tuesday, following the company's announcement of an unsolicited non-binding acquisition proposal. As of 12:25 p.m. EST, Global Cord Blood's stock was up ...

Alternate Ocean Investment, a wholly-owned subsidiary of Haitong International Securities (HTNGF) has made an offer to Global Cord Blood (CO) to acquire all of the outstanding ordinary shares for $5/share in cash. The Board will carefully review the unsolicited proposal to determine the ...

NanoViricides (NNVC) +112% on effectiveness of COVID-19 drug candidates in cell culture studies.Communications Systems (JCS) +38% after entering merger agreement with Pineapple Energy.STRATA Skin Sciences (SSKN) +30% on announcing CEO Transition.CHF Solutions (CHFS) +25%.AgeX T...

Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal Shareholders Advised to Take No Action Pending Board Review PR Newswire HONG KONG , March 2, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" ...